FcγRIIB controls antibody-mediated target cell depletion by ITIM-independent mechanisms

Many therapeutic antibodies deplete target cells and elicit immunotherapy by engaging activating Fc gamma receptors (FcγRs) on host effector cells. These antibodies are negatively regulated by the inhibitory FcγRIIB (CD32B). Dogma suggests inhibition is mediated through the FcγRIIB immunoreceptor ty...

Descripción completa

Detalles Bibliográficos
Autores principales: Simpson, Alexander P., Roghanian, Ali, Oldham, Robert J., Chan, H.T. Claude, Penfold, Christine A., Kim, Hyung J., Inzhelevskaya, Tatyana, Mockridge, C. Ian, Cox, Kerry L., Bogdanov, Yury D., James, Sonya, Tutt, Alison L., Rycroft, Daniel, Morley, Peter, Dahal, Lekh N., Teige, Ingrid, Frendeus, Björn, Beers, Stephen A., Cragg, Mark S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cell Press 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638011/
https://www.ncbi.nlm.nih.gov/pubmed/35858562
http://dx.doi.org/10.1016/j.celrep.2022.111099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638011/
https://www.ncbi.nlm.nih.gov/pubmed/35858562
http://dx.doi.org/10.1016/j.celrep.2022.111099

Ejemplares similares